Valentino, G.; Zivko, C.; Weber, F.; BrĂĽlisauer, L.; Luciani, P.
Synergy of Phospholipid—Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells. Pharmaceutics 2019, 11, 676.
https://doi.org/10.3390/pharmaceutics11120676
AMA Style
Valentino G, Zivko C, Weber F, BrĂĽlisauer L, Luciani P.
Synergy of Phospholipid—Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells. Pharmaceutics. 2019; 11(12):676.
https://doi.org/10.3390/pharmaceutics11120676
Chicago/Turabian Style
Valentino, Gina, Cristina Zivko, Florian Weber, Lorine BrĂĽlisauer, and Paola Luciani.
2019. "Synergy of Phospholipid—Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells" Pharmaceutics 11, no. 12: 676.
https://doi.org/10.3390/pharmaceutics11120676
APA Style
Valentino, G., Zivko, C., Weber, F., BrĂĽlisauer, L., & Luciani, P.
(2019). Synergy of Phospholipid—Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells. Pharmaceutics, 11(12), 676.
https://doi.org/10.3390/pharmaceutics11120676